Remove 2011 Remove Chemotherapy Remove FDA
article thumbnail

Q&A: How IQVIA Keeps Pharmacists Engaged with US Prescription Drug Use

Drug Topics

To have some context and our continuity with having done this now, since 2011, we've been publishing this report. Keeping that macro perspective, that overview, on a market this complex really helps you then dive into specific topics you're interested in. Often those very high-end medicines are for very few people.

article thumbnail

FDA looks at pulling speedy approvals for three cancer drugs

pharmaphorum

FDA advisors will scrutinise three cancer immunotherapies granted conditional approvals at a three-day meeting this week, to see if they should stay on the market. . Briefing documents published by the FDA ahead of the meeting suggest that discussion will focus on ongoing trials that may serve as alternative confirmatory studies.

FDA 90
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BMS lawsuit claims AZ’s Imjudo infringes Yervoy patents

pharmaphorum

BMS’ lawsuit claims that Imjudo (tremelimumab) infringes two patents covering its own CTLA4 drug Yervoy (ipilimumab), which has been on the market since 2011 and is a key component of combination therapies for cancer with BMS’ PD-1 inhibitor Opdivo (nivolumab).

article thumbnail

EU okays BMS’ azacitidine pill for first-line maintenance of AML

pharmaphorum

The EMA has cleared Onureg (formerly CC-486) as the first-ever orally-active drug that can be used for frontline maintenance treatment of AML who are in remission after initial chemotherapy but are not eligible for potentially curative therapies like a stem cell transplant. months from 14.8 months in a placebo-treated group.

article thumbnail

SPuMoNI: Enhancing Pharma Data Quality through Smart Technologies

ISPE

Directive 2011/62/EU of the European Parliament and of the Council.” Official Journal of the European Union (8 June 2011): 174–87. Published 2011. Mexican Governor: Cancer Children Given Water Instead of Chemotherapy.” 2 European Union. link] 3 Mascia, S., Lakerveld, B. Benyahia, P. Barton, R. Braatz, et al. 30 June 2016.

article thumbnail

STAT+: Pharmalittle: FDA panel says popular decongestant doesn’t work; U.S. warns companies over illegally marketed eye products

STAT

plummeted nearly 45% between 2011 and 2019, new federal data show, even as fatal overdoses rose to record levels as users increasingly used heroin, and then illegal fentanyl, The Washington Post reports. Once again, we hope you have a successful day and, of course, keep in touch. We enjoy hearing your tips and tidbits.

FDA 94
article thumbnail

A history of blood cancer treatment

pharmaphorum

While they may not have known it at the time, through their work Ehrlich and Metschnikow formed the cornerstone of modern immunology, including chemoreceptor and chemotherapy concepts that revolutionised blood cancer treatment over the following century. 1942 – Chemotherapy moves from trenches to treatment .